Article
Resmetirom Attenuates Atherosclerosis in ApoE ⁻/⁻ Mice by Suppressing the NF- κB/ROS–NLRP3 Inflammasome Axis
2026-02-24
Abstract excerpt
<title>Abstract</title> <p> Atherosclerosis is a chronic inflammatory vascular disease in which the NLRP3 inflammasome and NF-κB signaling play central pathogenic roles. Resmetirom, a liver-selective thyroid hormone receptor β (THR-β) agonist approved for metabolic dysfunction-associated steatohepatitis (MASH), exhibits potent lipid-lowering effects, yet its anti-inflammatory actions in atherosclerosis remain un...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9bdb9d0b-5862-58a1-bf9b-70e18fd72a7b
- DOI
- 10.21203/rs.3.rs-8902352/v1
